T
Theriva Biologics, Inc. (TOVX)
ASE – Real vaqt narxi. Valyuta: USD
0.24
+0.01 (4.09%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
0.24
-0.00 (-0.08%)
Bozordan keyin: Aug 12, 2026, 4:19 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.24
+0.01 (4.09%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
0.24
-0.00 (-0.08%)
Bozordan keyin: Aug 12, 2026, 4:19 PM EDT
Theriva Biologics, Inc., klinik bosqichdagi kompaniya, Qo'shma Shtatlarda yuqori darajada ehtiyoj sezilayotgan sohalarda saraton va unga bog'liq kasalliklarni davolash uchun terapevtik vositalarni ishlab chiqadi. Uning asosiy mahsulot nomzodi, VCN-01 (zabilugene almadenorepvec), klinik bosqichdagi onkolitik inson adenovirusi bo'lib, u oshqozon osti bezi saratoni, bosh va bo'yinning yassi hujayrali karsinomasi, tuxumdon saratoni, kolorektal saraton va retinoblastoma bilan og'rigan bemorlar uchun 1-bosqich klinik sinovlarida va 2-bosqich VIRAGE sinovida. Kompaniya, shuningdek, qattiq o'smalarni davolash uchun VCN-11ni; allogenik gematopoez hujayralari transplantatsiyasi (HCT)da o'tkir ko'chiruvchi-xost kasalligining (aGVHD) oldini olish uchun 1b/2a bosqichli klinik sinovlarda bo'lgan og'zaki kapsula profilaktik terapiyasi SYN-004 (ribaxamase)ni; va ko'plab me'da-ichak va metabolik ko'rsatkichlar uchun ichak ishqoriy fosfataza (IAP) fermentining rekombinant og'zaki shakli bo'lgan SYN-020ni ishlab chiqadi. Bundan tashqari, u karbapenem antibiotiklari bilan davolanayotgan bemorlarda aGVH, clostridioides difficile infektsiyasi va mikrobioma shikastlanishining oldini olish uchun SYN-006 kabi klinik bosqichdagi mahsulotlarni; va og'zaki β-laktam antibiotiklari bilan antibiotik bilan bog'liq diareyaning oldini olish uchun SYN-007ni ishlab chiqadi. Kompaniya SYN-020ni o'z ichiga olgan har qanday mahsulotni tadqiq qilish, ishlab chiqish, ishlab chiqarish va tijoratlashtirish bo'yicha Rasayana Therapeutics, Inc. bilan litsenzion kelishuvga ega, shuningdek, SYN-004ning 1b/2a bosqichli klinik sinovini o'tkazish uchun Vashington universiteti tibbiyot maktabi bilan klinika sinovlari kelishuviga ega. Theriva Biologics, Inc.ning shtab-kvartirasi Rokvill, Merilendda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ramon Alemany Ph.D. | Senior Vice President of Discovery |
| Dr. Vince Wacher Ph.D. | Senior Vice President of Corporate & Product Development |
| Mr. Steven A. Shallcross CPA | CEO, CFO, Treasurer, Corporate Secretary & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-11 | 8-K | tm2622636d1_8k.htm |
| 2026-08-11 | 10-Q | tmb-20260630x10q.htm |
| 2026-08-06 | 8-K | tm2622359d1_8k.htm |
| 2026-08-04 | 8-K | tm2619846d1_8k.htm |
| 2026-07-07 | 8-K | tm2619846d1_8k.htm |
| 2026-06-29 | DEF 14A | tm2618124d1_def14a.htm |
| 2026-06-18 | PRE 14A | tm2618124d1_pre14a.htm |
| 2026-06-11 | 8-K | tm2617564d1_8k.htm |
| 2026-06-05 | 8-K | tm2616886d1_8k.htm |
| 2026-05-05 | 8-K | tm2613605d1_8k.htm |